A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TOP1288 Oral Single Ascending and Multiple Doses in Healthy Volunteers

Trial Profile

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of TOP1288 Oral Single Ascending and Multiple Doses in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2017

At a glance

  • Drugs TOP 1288 (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors TopiVert
  • Most Recent Events

    • 06 Jul 2017 Status changed from recruiting to completed.
    • 28 Feb 2017 Status changed to recruiting.
    • 06 Oct 2016 Results from this trial are expected in the second half of 2017, according to a TopiVert media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top